Lymphoid blast crisis after prolonged treatment‐free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de‐escalation during the COVID‐19 pandemic
Abstract During the COVID‐19 pandemic, access to health services has been considerably restricted and furthermore, patients have been reluctant to attend for routine monitoring, and this may have had a negative impact in the management of patients affected with haematological disorders. Sudden blast...
Main Authors: | Daniele Avenoso, Dragana Milojkovic, James Clark, Christopher Pocock, Victoria Potter, Deborah Yallop, Guy Hannah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.302 |
Similar Items
-
Extensive cutaneous manifestations: Presenting feature of chronic myelocytic leukemia in second blast crisis
by: Singhal Manish, et al.
Published: (2010-01-01) -
Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)
by: Jusuf Imeri, et al.
Published: (2023-02-01) -
A rare case of B-lymphoid blast phase of chronic myeloid leukemia: Diagnostic challenges
by: Nada Naiyer, MD, et al.
Published: (2022-01-01) -
Validation of CIP2A as a Biomarker of Subsequent Disease Progression and Treatment Failure in Chronic Myeloid Leukaemia
by: Richard E. Clark, et al.
Published: (2021-04-01) -
Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model
by: Jusuf Imeri, et al.
Published: (2024-01-01)